Sixty adolescents and young adults with ESKD ( @ on hemodialysis and @ kidney transplant recipients ) were randomized @:@ to receive a traditional trivalent split virion vaccine ( TIIV ) or a virosome-adjuvanted trivalent inactivated influenza vaccine ( VATIIV ) .